SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anu’s Laboratories reports net loss of Rs 5.29 crore in Q1

17 Aug 2012 Evaluate

Anu’s Laboratories has reported results for first quarter ended June 30, 2012.

The company has reported a net loss of Rs 5.29 crore for the quarter under review as compared to a net profit of Rs 4.18 crore for the same quarter in the previous year. The total income of the company has decreased by 46.51% at Rs 37.58 crore for Q1FY13 as compared Rs 70.26 crore for the corresponding quarter previous year.

Anu's Laboratories is engaged in the manufacture of quality drug intermediates to meet the needs of international customers. Its state-of-the-art R&D facilities, located at Balanagar, Hyderabad, support the process of product development, contract research and customised synthesis programmes of the organization.

Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×